Geode Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $990M | Buy |
|
|||||
|
2025
Q1 | $915M | Sell |
|
|||||
|
2024
Q4 | $1.01B | Buy |
|
|||||
|
2024
Q3 | $889M | Buy |
|
|||||
|
2024
Q2 | $1.22B | Buy |
|
|||||
|
2024
Q1 | $1.25B | Buy |
|
|||||
|
2023
Q4 | $978M | Buy |
|
|||||
|
2023
Q3 | $877M | Buy |
|
|||||
|
2023
Q2 | $1.17B | Buy |
|
|||||
|
2023
Q1 | $1.01B | Buy |
|
|||||
|
2022
Q4 | $904M | Buy |
|
|||||
|
2022
Q3 | $985M | Buy |
|
|||||
|
2022
Q2 | $1.11B | Buy |
|
|||||
|
2022
Q1 | $1.35B | Buy |
|
|||||
|
2021
Q4 | $1.43B | Buy |
|
|||||
|
2021
Q3 | $1.19B | Buy |
|
|||||
|
2021
Q2 | $1.06B | Buy |
|
|||||
|
2021
Q1 | $827M | Buy |
|
|||||
|
2020
Q4 | $891M | Sell |
|
|||||
|
2020
Q3 | $799M | Sell |
|
|||||
|
2020
Q2 | $700M | Sell |
|
|||||
|
2020
Q1 | $646M | Sell |
|
|||||
|
2019
Q4 | $818M | Buy |
|
|||||
|
2019
Q3 | $725M | Buy |
|
|||||
|
2019
Q2 | $505M | Sell |
|
|||||
|
2019
Q1 | $561M | Sell |
|
|||||
|
2018
Q4 | $450M | Buy |
|
|||||
|
2018
Q3 | $476M | Buy |
|
|||||
|
2018
Q2 | $387M | Buy |
|
|||||
|
2018
Q1 | $356M | Buy |
|
|||||
|
2017
Q4 | $270M | Buy |
|
|||||
|
2017
Q3 | $252M | Buy |
|
|||||
|
2017
Q2 | $265M | Sell |
|
|||||
|
2017
Q1 | $214M | Buy |
|
|||||
|
2016
Q4 | $201M | Buy |
|
|||||
|
2016
Q3 | $248M | Buy |
|
|||||
|
2016
Q2 | $194M | Buy |
|
|||||
|
2016
Q1 | $166K | Buy |
|
|||||
|
2015
Q4 | $144M | Buy |
|
|||||
|
2015
Q3 | $127M | Sell |
|
|||||
|
2015
Q2 | $135M | Buy |
|
|||||
|
2015
Q1 | $134M | Buy |
|
|||||
|
2014
Q4 | $112M | Buy |
|
|||||
|
2014
Q3 | $86.5M | Sell |
|
|||||
|
2014
Q2 | $72.9M | Buy |
|
|||||
|
2014
Q1 | $57.5M | Sell |
|
|||||
|
2013
Q4 | $51.6M | Sell |
|
|||||
|
2013
Q3 | $55.5M | Buy |
|
|||||
|
2013
Q2 | $52.1M | Buy |
|